# Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft in AV Graft Patients (AVeVA)

> **NCT02790606** · NA · COMPLETED · sponsor: **C. R. Bard** · enrollment: 110 (actual)

## Conditions studied

- Stenosis
- Restenosis

## Interventions

- **DEVICE:** Covera(TM) Vascular Covered Stent

## Key facts

- **NCT ID:** NCT02790606
- **Lead sponsor:** C. R. Bard
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2017-08
- **Final completion:** 2019-03-16
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2020-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02790606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02790606, "Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft in AV Graft Patients (AVeVA)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02790606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*